<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S77 IS: Prescription Drug and Health Improvement Act of 2013</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2013-01-23</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 77</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130123" legis-day="20130103">January 23
			 (legislative day, January 3), 2013</action-date>
			<action-desc><sponsor name-id="S332">Mr. Franken</sponsor> (for himself
			 and <cosponsor name-id="S311">Ms. Klobuchar</cosponsor>) introduced the
			 following bill; which was read twice and referred to the
			 <committee-name committee-id="SSFI00">Committee on
			 Finance</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend part D of title XVIII of the Social Security Act
		  to authorize the Secretary of Health and Human Services to negotiate for lower
		  prices for Medicare prescription drugs.</official-title>
	</form>
	<legis-body>
		<section id="idD874E100A4184C7F8B22AB8526AEEA7E" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Prescription Drug and Health
			 Improvement Act of 2013</short-title></quote>.</text>
		</section><section id="id09832F88937D4F18BC6BBC61D90B5858" section-type="subsequent-section"><enum>2.</enum><header>Negotiating fair
			 prices for medicare prescription drugs</header>
			<subsection id="IDD957981F6BE741E382087FD1FE0B860C"><enum>(a)</enum><header>Negotiating
			 fair prices</header>
				<paragraph id="id8A7503A3469F44F5B96828557B005632"><enum>(1)</enum><header>In
			 general</header><text>Section 1860D–11 of the <act-name parsable-cite="SSA">Social Security Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-111">42 U.S.C. 1395w–111</external-xref>) is
			 amended by striking subsection (i) (relating to noninterference) and by
			 inserting the following:</text>
					<quoted-block act-name="Social Security Act" id="ID95576C94CE384DCCB810F4AAB15B1895" style="OLC">
						<subsection id="ID73AC92EA6D0F4DD9A877301D1B94A701"><enum>(i)</enum><header>Authority To
				negotiate prices with manufacturers</header><text>In order to ensure that
				beneficiaries enrolled under prescription drug plans and MA–PD plans pay the
				lowest possible price, the Secretary shall have authority similar to that of
				other Federal entities that purchase prescription drugs in bulk to negotiate
				contracts with manufacturers of covered part D drugs, consistent with the
				requirements and in furtherance of the goals of providing quality care and
				containing costs under this
				part.</text>
						</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph><paragraph id="IDC939CBFA45324369946A0D21C8C71757"><enum>(2)</enum><header>Effective
			 date</header><text>The amendment made by paragraph (1) shall take effect on the
			 date of the enactment of this Act.</text>
				</paragraph></subsection><subsection id="IDeda4019c386d427abb844f4e4718f0f9"><enum>(b)</enum><header>Biannual
			 reports to Congress</header><text>Not later than 1 year after the date of the
			 enactment of this Act, and every 6 months thereafter, the Secretary of Health
			 and Human Services shall submit to Congress a report on the negotiations
			 conducted by the Secretary under section 1860D–11(i) of the Social Security Act
			 (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-111">42 U.S.C. 1395w–111(i)</external-xref>), as amended by subsection (a), including a description
			 of how such negotiations are achieving lower prices for covered part D drugs
			 (as defined in section 1860D–2(e) of the <act-name parsable-cite="SSA">Social
			 Security Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-102">42 U.S.C. 1395w–102(e)</external-xref>)) for Medicare
			 beneficiaries.</text>
			</subsection></section></legis-body>
</bill>


